8-K
File 001-36407
ALNYLAM PHARMACEUTICALS, INC. 8-K
- Filing date
- 31 Oct 2019
- Reporting date
- 31 Oct 2019
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
ALNYLAM PHARMACEUTICALS, INC. reports
- Company location
- Cambridge, MA
- Fiscal year end
- 31 December
Company
Names, identifiers, and filing context for this profile.
1 identity field
SEC filing record 1 source field available
ALNYLAM PHARMACEUTICALS, INC. has filed 1,680 SEC EDGAR filings since 09 Jul 2002
SEC filing history
Showing 76-100 of 207 matching filings.
Per page
25
Current page
4
8-K
File 001-36407
8-K
- Filing date
- 03 Oct 2019
- Reporting date
- 27 Sep 2019
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-36407
ALNYLAM PHARMACEUTICALS, INC. 8-K
- Filing date
- 06 Aug 2019
- Reporting date
- 06 Aug 2019
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
FORM 8-K
- Filing date
- 11 Jul 2019
- Reporting date
- 08 Jul 2019
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
8-K
- Filing date
- 21 May 2019
- Reporting date
- 21 May 2019
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
ALNYLAM PHARMACEUTICALS, INC. 8-K
- Filing date
- 01 May 2019
- Reporting date
- 01 May 2019
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
8-K
- Filing date
- 26 Apr 2019
- Reporting date
- 25 Apr 2019
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
8-K
- Filing date
- 09 Apr 2019
- Reporting date
- 08 Apr 2019
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
ALNYLAM PHARMACEUTICALS, INC. 8-K
- Filing date
- 07 Feb 2019
- Reporting date
- 07 Feb 2019
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
8-K
- Filing date
- 15 Jan 2019
- Reporting date
- 14 Jan 2019
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
8-K
- Filing date
- 07 Jan 2019
- Reporting date
- 07 Jan 2019
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
8-K
- Filing date
- 10 Dec 2018
- Reporting date
- 09 Dec 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
ALNYLAM PHARMACEUTICALS, INC. 8-K
- Filing date
- 07 Nov 2018
- Reporting date
- 07 Nov 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
8-K
- Filing date
- 10 Oct 2018
- Reporting date
- 09 Oct 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
8-K
- Filing date
- 02 Oct 2018
- Reporting date
- 27 Sep 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
8-K
- Filing date
- 17 Aug 2018
- Reporting date
- 14 Aug 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
FORM 8-K
- Filing date
- 10 Aug 2018
- Reporting date
- 10 Aug 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
ALNYLAM PHARMACEUTICALS, INC. 8-K
- Filing date
- 02 Aug 2018
- Reporting date
- 02 Aug 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
8-K
- Filing date
- 15 May 2018
- Reporting date
- 10 May 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
ALNYLAM PHARMACEUTICALS, INC. 8-K
- Filing date
- 03 May 2018
- Reporting date
- 03 May 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
8-K
- Filing date
- 20 Apr 2018
- Reporting date
- 18 Apr 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
8-K
- Filing date
- 03 Apr 2018
- Reporting date
- 28 Mar 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
FORM 8-K
- Filing date
- 14 Mar 2018
- Reporting date
- 08 Mar 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
ALNYLAM PHARMACEUTICALS, INC. 8-K
- Filing date
- 08 Feb 2018
- Reporting date
- 08 Feb 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-36407
8-K
- Filing date
- 08 Jan 2018
- Reporting date
- 06 Jan 2018
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing